Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma
It was not MASLD, but rather the presence of multiple cardiometabolic risk factors in patients with CHB that was associated with the risk of HCC in those receiving antiviral treatment. Furthermore, older age, male sex, diabetes, and cirrhosis aggravated the risk of HCC in patients with CHB.
Authors
- Hüseyin Aykut (ORCID: https://orcid.org/0000-0001-7827-8115)
- Nermin Mutlu Bilgiç (ORCID: https://orcid.org/0000-0003-0486-1767)
- Gupse Adalı (ORCID: https://orcid.org/0000-0003-2157-0304)
- Yusuf Nadir Yilmaz (ORCID: https://orcid.org/0000-0003-4518-5283)
Institutions
- Recep Tayyip Erdoğan University (TR)
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37990
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Recep Tayyip Erdogan Üniversitesi